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Haem is an essential cofactor that in pathogens is obtained by means of an internal haem biosynthesis 
pathway and/or from the host by a capture system. Here it is shown for the first time that pathogens 
possessing the two systems communicate through a haem monooxygenase enzyme of the IsdG-
family type. The importance of this crosstalk lies in the need for pathogens to reconcile their high 
haem requirements with the paradox that free haem is toxic.  
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Haem is an essential cofactor in central metabolic pathways in the vast majority of living systems. 36 
Prokaryotes acquire haem via haem biosynthesis pathways, and some also utilize haem uptake systems, 37 
yet it remains unclear how they balance haem requirements with the paradox that free haem is toxic. 38 
Here, using the model pathogen Staphylococcus aureus, we report that IsdG, one of two haem 39 
oxygenase enzymes in the haem uptake system, inhibits the formation of haem via the internal haem 40 
biosynthesis route. More specifically, we show that IsdG decreases the activity of ferrochelatase and 41 
that the two proteins interact both in vitro and in vivo. Further, a bioinformatics analysis reveals that a 42 
significant number of haem biosynthesis pathway containing organisms possess an IsdG-homologue and 43 
that those with both biosynthesis and uptake systems have at least two haem oxygenases. We conclude 44 
that IsdG-like proteins control intracellular haem levels by coupling the two pathways. IsdG is thus a 45 
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Introduction 
In all forms of life, the ability to perform redox reactions is crucial, often requiring compounds with 
metal centres and cofactors that are evolutionarily ancient. Haem is an iron-based redox centre that is 
widely distributed in living organisms and which permits an extensive range of proteins and enzymes to 
function in essential cellular processes such as aerobic and anaerobic respiration, detoxification, 
microRNA processing and regulation of gene expression (Choby and Skaar, 2016). Haem is obtained by 
either de novo synthesis (via haem biosynthesis pathways) or by uptake from the environment. Several 
pathogens extract haem from their host’s haemoglobin, which upon degradation serves as a source of 
iron to satisfy the nutritional needs of the pathogen (Anzaldi and Skaar, 2010; Choby and Skaar, 2016). 
Furthermore, a large number of microorganisms combine pathways for the endogenous production of 
haem with complex haem uptake systems.  
Prokaryotes utilise one of three distinct haem biosynthesis pathways, all of which have common early 
steps that lead to the intermediate uroporphyrinogen III (Fig. 1). Thereafter, the three distinct routes are 
referred to as the protoporphyrin, sirohaem and coproporphyrin branches, reflecting intermediates that 
are unique to each pathway, and the genes involved were recently renamed (Dailey et al., 2017). The 
protoporphyrin dependent (PPD) branch, previously known as classic pathway, operates in many Gram-
negative bacteria. This pathway involves the decarboxylation of uroporphyrinogen III to 
coproporphyrinogen III by UroD (formerly HemE), followed by decarboxylation to protoporphyrinogen IX 
by CgdH/CgdC (formerly HemN/HemF) and then oxidation to protoporphyrin IX by PgoX/PgdH1 
(formerly HemY/HemG) prior to metal insertion by ferrochelatase PpfC (formerly HemH) to give 
protohaem (Heinemann et al., 2008; Dailey et al., 2017). The sirohaem dependent branch (SHD), 
originally named the alternative haem biosynthesis pathway Ahb, is active in sulphate-reducing 
proteobacteria and archaea, transforms uroporphyrinogen III to protohaem via sirohaem in an oxygen-
independent process requiring four-enzymatic steps involving the enzymes AhbA-D (Bali et al., 2011; 
Lobo et al., 2012). The most recently discovered branch, namely the coproporphyrin dependent (CPD) 
pathway is active in several Gram-positive organisms including S. aureus (Lobo et al., 2015). This 
pathway involves the conversion of uroporphyrinogen III to coproporphyrinogen III by UroD (formerly 
HemE) and subsequent oxidation to coproporphyrin III by CgoX (formerly HemY). Insertion of iron into 
coproporphyrin III to make coprohaem is mediated by CpfC (formerly HemH), and the final step involves 
the decarboxylation of coprohaem to protohaem by ChdC (formerly HemQ) (Dailey et al., 2015; Lobo et 
al., 2015). Although these ferrochelatases catalyse the insertion of iron in a porphyrin ring, the substrate 
that they act upon is different, being protoporphyrin IX for PPD, coproporphyrin III for CPD and 
sirohydrochlorin for SHD pathways.  
The mechanisms of haem biosynthesis in prokaryotes vary widely (Dailey et al., 2017) and control over 
the pathway has been reported to be regulated by iron, oxygen, reactive oxygen species and by its final 
product haem (Choby and Skaar, 2016; Dailey et al., 2017). In the case of the latter, the binding of haem 
to GtrR (formerly HemA), the first enzyme of the pathway, is thought to control the system via a 
4 
feedback inhibition mechanism (McNicholas et al., 1997; Wang et al., 1997; Choby and Skaar, 2016).The 109 
most common haem acquisition system in Gram-positive pathogens is the iron-regulated surface 110 
determinant (Isd). S. aureus also contains an additional  haem transport system (Hts) that, like the Isd 111 
proteins, was first described in this bacterium (Mazmanian et al., 2003; Skaar EP, Humayun M, Bae T, 112 
DeBord KL, 2004). The Isd system includes the cell wall-anchored proteins IsdA, IsdB, IsdC and IsdH, as 113 
well as the haem-binding protein and permease components IsdD, IsdE, and IsdF, and the 114 
transmembrane ABC transporter HtsABC
 
(Mazmanian et al., 2003; Skaar EP, Humayun M, Bae T, DeBord 115 
KL, 2004). Once haem is transported into the cytoplasm, it is either degraded by the haem 116 
monooxygenases IsdG and IsdI to release iron (Skaar et al., 2004), or becomes bound to membrane-117 
associated proteins to act as a cofactor in, for example, electron transport (Thöny-Meyer, 1997). S. 118 
aureus also possesses the haem regulated transporter (HrtAB), an efflux pump that protects cells from 119 
haem toxicity (Stauff et al., 2008).  120 
S. aureus is clinically significant as it is responsible for a large number of human infections including121 
respiratory, urogenital, skin burn-associated and systemic infections (Tarai et al., 2013). It is also a 122 
widely studied Gram-positive pathogen and the paradigm for the CPD pathway operating alongside a 123 
haem acquisition system. Genes encoding enzymes of the CPD pathway are organized into two operons 124 
in S. aureus, gtrR-hemX-hmbS-uroS-pbgS  and uroD-cpfC-cgoX, whereas chdC is isolated elsewhere in the 125 
genome (Lobo et al., 2015). The S. aureus haem acquisition system is formed by single units isdA, isdB, 126 
isdH, isdI and the operon isdCDEF-srtB-isdG (Mazmanian et al., 2003; Skaar and Schneewind, 2004). Like 127 
many other organisms, S. aureus encodes two haem monooxygenases, IsdG and IsdI, which share 128 
approximately 70% amino acid identity and which bind and degrade haem to produce iron and 129 
staphylobilin (Skaar et al., 2004; Reniere et al., 2010).   130 
 In this work, we investigated how S. aureus controls intracellular haem levels. We show that the haem 131 
monooxygenase, IsdG, provides a link between the haem biosynthesis and uptake pathways in S. aureus 132 
and that this protein prevents excessive formation of toxic haem inside bacterial cells. 133 
134 
135 









































The haem monooxygenase IsdG interferes with haem formed via the haem biosynthesis pathway 
To analyse the role of the two haem monooxygenases of S. aureus, the S. aureus CPD pathway was 
reconstituted in a haemin auxotrophic strain of the Gram-negative bacterium E. coli that is deficient in 
protoporphyrin ferrochelatase ΔppfC (formerly ΔvisA or ΔhemH). As E. coli does not take up exogenous 
haem through an Isd system, this host represents a good model to study the role of IsdG/I enzymes 
without the interference of an endogenous haem acquisition system, thus avoiding the use of S. aureus 
strains containing multiple mutations. The genes encoding the last three enzymes of the S. aureus CPD 
pathway, cgoX-cpfC-chdC, were cloned by the Link and Lock method (McGoldrick et al., 2005), expressed 
in the presence of either IsdG or IsdI in E. coli ΔppfC, and growth of the complemented strain was 
monitored. The results showed that expression of CgoX-CpfC-ChdC alone abolished the haem auxotrophy 
of the strain, which grows similar to an E. coli wild type strain. However, in the presence of either IsdG or 
IsdI, the growth of the strain was impaired (Fig. 2A).   
In order to understand the growth behaviour of the complemented strains, the tetrapyrrole products 
formed during the expression of S. aureus cgoX-cpfC-chdC genes in the presence of IsdI or IsdG were 
analysed by HPLC-MS. As expected, cells expressing S. aureus CgoX-CpfC-ChdC exhibited a peak with a 
mass-to-charge ratio (m/z) of 616, confirming their ability to produce haem. However, this peak 
significantly decreased when IsdG or IsdI were also expressed (Fig. 2B), with cells expressing S. aureus 
CgoX-CpfC-ChdC-IsdI containing approximately 3 times less haem, and cells expressing CgoX-CpfC-ChdC 
together with IsdG showing no detectable peak corresponding to haem. These results suggest that the 
haem monooxygenases interfere with the haem formation in vivo. 
The lack of growth in the presence of IsdG/I enzymes indicated that no haem was being formed, which 
could result from degradation and/or inhibition of its formation. To test these possibilities, we analysed 
the growth of E. coli ΔppfC, complemented with its own ferrochelatase PpfC and in the presence of IsdI 
or IsdG. Under these conditions where the haem is formed through the PPD pathway, it was observed 
that only IsdI impaired the growth while IsdG had no effect (Fig. 2C). 
Hence, we conclude that IsdI always acts as a haem monoxygenase as it degrades haem independently 
of whether it is formed by the CPD or PPD pathways while IsdG impairs the growth of the strain using 
the CPD pathway but not of the strain using the PPD pathway suggesting that IsdG is not acting as a 
haem degrading enzyme.   
IsdG decreases the ferrochelatase activity of CpfC 
To understand how the S. aureus IsdG and IsdI constrain the CPD pathway, we tested whether they 
interfere with the activity of the S. aureus ChdC enzyme that catalyses the last step of the CPD branch 
promoting the conversion of iron-coproporphyrin III into haem in the presence of its electron acceptor 174 
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(Lobo et al., 2015). Thus, S. aureus ChdC was incubated with iron-coproporphyrin III in the presence of 175 
either IsdG or IsdI and hydrogen peroxide. However, control experiments performed in the absence of 176 
ChdC showed that hydrogen peroxide activates the inherent peroxidase activity in IsdG and IsdI, leading 177 
to degradation of the iron-coproporphyrin III substrate (Fig. S1). We therefore shifted our attention to 178 
the penultimate enzyme of the CPD branch, the ferrochelatase CpfC, which plays an important role in 179 
the survival of S. aureus (Fig. S2), as also shown for the GtrR and PbgS enzymes involved in the first steps 180 
of the CPD pathway (Hammer et al., 2013; Hammer et al., 2014). 181 
In S. aureus and other Gram-positive operating via the CPD pathway, the ferrochelatase incorporates 182 
iron into coproporphyrin III to form iron-coproporphyrin III, which is then sequentially decarboxylated 183 
by ChdC to yield protohaem. We observed that the cell lysate of S. aureus cpfC mutant contained very 184 
low levels of cellular catalase activity, which was restored to wild type level upon addition of external 185 
haemin (Fig. S3). It was previously reported that the total cellular catalase activity was lower in S. aureus 186 
pbgS and chdC defective strains (Mayfield et al., 2013). We next tested whether the haem 187 
monooxygenases impaired ferrochelatase activity. S. aureus CpfC, IsdG and IsdI were recombinantly 188 
produced and purified, yielding stable proteins that had the expected molecular masses of 189 
approximately 35 and 12.5 KDa, respectively (data not shown). S. aureus ferrochelatase activity was 190 





. While addition of IsdI to the reaction mixture caused no significant alteration (Fig. 3A), 192 
the presence of IsdG led to a ~50% decrease in ferrochelatase activity. Furthermore, the activity of the 193 
enzyme decreased with increasing concentration of IsdG (Fig 3B). 194 
These results show that IsdG, but not IsdI, attenuates the activity of the S. aureus CpfC. Therefore, we 195 
next determined the haem cellular content in cells forming haem by the CPD pathway in the presence 196 
and absence of IsdG. For this purpose, S. aureus wild type and ΔisdG mutant cells were grown in the 197 
presence of aminolaevulinic acid, the first stable precursor of the haem biosynthesis pathway. Figure 3C 198 
shows that the IsdG inactivated strain has significantly higher haem content.  Therefore, we conclude 199 
that IsdG impairs CpfC lowering the amount of haem formed by the CPD pathway. 200 
201 
202 
Protein-protein interaction studies between IsdG and CpfC 203 
204 
We reasoned that the inhibition of the S. aureus CpfC activity by IsdG is most likely a result from a direct 205 
interaction between the two proteins. Three type of experiments were done; pull down assays, Förster 206 
resonance energy transfer (FLIM-FRET) and fluorescence polarization binding experiments. 207 
208 
For the pull down assays, purified CpfC-His tagged protein bound to a Ni-Sepharose column was 209 
incubated with cells extracts expressing IsdG or IsdI. The bound proteins were eluted with imidazole 210 
containing buffer and separated electrophoretically.  As visualised by SDS-PAGE, IsdG is pulled down 211 
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together with CpfC, while IsdI does not bind to the column-loaded CpfC (Fig. 4A). Hence, the results 212 




































To further study this interaction in vivo fluorescence lifetime imaging based Förster resonance energy 
transfer (FLIM-FRET) was used. Additionally, interactions among the various CPD pathway protein 
components and S. aureus haem monooxygenases were also evaluated. In order to do this, we 
constructed S. aureus CpfC and ChdC proteins fused to a GFP donor molecule and IsdG, IsdI, ChdC and 
CpfC fused to a mCherry acceptor molecule (Table S1).   
The interaction between IsdG and CpfC was analysed in bacterial cells expressing S. aureus CpfC-GFP and 
IsdG-mCherry. CpfC-GFP exhibited a mono-exponential fluorescence decay with a lifetime τCpfC-EGFP = 2.2 
± 0.1 ns (Fig S4). In the presence of IsdG-mCherry, the fluorescence decay of CpfC-GFP was no longer 
accurately described by a single exponential and a shorter component had to be included in the fit, 
indicating the presence of FRET and thus an interaction between the two proteins (Fig. 4 and Fig S4). The 
FRET efficiencies (E) were dependent on the concentration of IsdG, according to the plots of E against 
mCherry/GFP fluorescence intensity ratios (Fig. 4), obtained from the confocal fluorescence 
measurements of each construct (see Methods).  
Although some degree of interaction between CpfC-GFP and IsdI-mCherry was also detected (Fig. 4B 
and 4D), the FRET efficiencies determined for this protein pair were much lower than those measured 
for IsdG and CpfC (Fig. 4C), suggesting a much less efficient interaction. Furthermore, an interaction 
between ChdC and IsdG, but not ChdC and IsdI, was also observed (Fig. 4E and 4F).  
Together, these data reveal that IsdG interacts with the last two enzymes of the CPD pathway, namely 
CpfC and ChdC.  
The FLIM-FRET protein-protein interaction studies were complemented with an in vitro homogeneous 
fluorescence polarization binding assay to monitor macromolecular complex formation between the 
two recombinant S. aureus proteins, CpfC and IsdG. For this purpose, S. aureus CpfC was covalently 
conjugated to dansyl chloride, a long-lived fluorescent probe, in order to evaluate its binding to IsdG 
using both steady-state and time-resolved fluorescence anisotropy measurements (Valeur and 
Berberan-Santos, 2012). The dansyl-labeled CpfC gave a high steady-state fluorescence anisotropy in 
solution (<r> = 0.164 ± 0.002; Fig. 4G and Fig. S5). Upon increasing the concentration of dimeric IsdG in 
solution, the steady-state fluorescence anisotropy of dansyl-CpfC steadily augmented (Fig. S6) reaching a 
plateau level of <r> ~ 0.20 (Fig. 4G). In contrast, there was negligible binding observed between IsdI 
and CpfC. Upon binding of dimeric IsdG to dansyl-labeled CpfC, the hydrodynamic volume of the protein 
complex increased, slowing down the overall rotational tumbling of dansyl-labeled CpfC in solution 
during its excited-state fluorescence lifetime and ultimately producing an increase in its steady-state 
fluorescence anisotropy
 
(Jameson and Ross, 2010; Valeur and Berberan-Santos, 2012). These data were 
further corroborated by time-resolved polarized fluorescence measurements of dansyl-labeled CpfC 
during its titration with IsdG. The fluorescence anisotropy decay of dansyl-labeled CpfC was greatly 249 
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affected by addition of IsdG to the solution (Fig. S6). In particular, the longer rotational correlation time, 250 
φ2, assigned to the overall rotational motion of dansyl-labeled CpfC in solution, increased significantly 251 
from φ2 ~ 67 ns for dansyl-labeled CpfC free in solution to φ2 ~ 180 ns for dansy-labeled CpfC in the 252 
presence of 107 M IsdG (Fig. 4H and Table S2). A binding Kd of 14.3 ± 2.6 µM (for the dimeric form of 253 
IsdG) and a <r>B of 0.207 ± 0.003 was determined. These results clearly demonstrate that IsdG has the 254 
ability to bind to CpfC in solution at physiological pH.  255 
256 
Haemin increases IsdG expression 257 
258 
To assess the impact of haem uptake by the host to its endogenous haem biosynthesis, we determined 259 
the expression of the haem biosynthesis genes in S. aureus cells grown in medium supplemented with 260 
haemin (2.5 µM). Addition of external haemin modified the mRNA content of gtrR, uroD and chdC (Fig. 261 
5A). A similar change was observed with the genes encoding the iron-regulated surface determinants 262 
isdA, isdB and isdI, while hrtB and htsA were strongly upregulated (Fig. 5A). Treatment with exogenous 263 
haemin also caused a significant induction of the isdCDEG operon (Fig. 5A).  264 
The pronounced change in isdG gene expression led us to analyse the amount of IsdG protein in cells 265 
containing excess haem, which was either added exogenously to the medium or produced 266 
endogenously through supplementation with aminolaevulinic acid. For this purpose, an IsdG-GFP fusion 267 
protein was constructed and the amount of IsdG was determined by the direct measurement of the 268 
fluorescence derived from the construct by flow cytometry. For comparative purposes, an IsdI-GFP 269 
fusion protein was also constructed. S. aureus expressing GFP, IsdG-GFP or IsdI-GFP were grown in 270 
either TSB supplemented with haemin or TSB containing an excess of aminolaevulinic acid. Addition of 271 
haemin increased the levels of IsdG, which was evidenced by the higher fluorescence of S. aureus cells 272 
expressing IsdG-GFP compared to cells expressing GFP alone (Fig. 5B). Cells expressing IsdI-GFP showed 273 
slightly higher fluorescence than cells expressing GFP alone, however at a much lower extent than cells 274 
containing IsdG-GFP (Fig. 5B). Interestingly, addition of aminolaevulinic acid caused an increase in 275 
fluorescence, revealing that internally produced haem also augments the cellular content of IsdG (Fig. 276 
5C). In contrast, supplementation with aminolaevulinic acid produced a strong decrease of fluorescence 277 
in cells expressing IsdI-GFP. Therefore, the increase in the intracellular content of IsdG promoted by 278 
haem may trigger the interaction of IsdG with CpfC with a consequential impairment of the CPD 279 
pathway.   280 
281 
282 
IsdG-like proteins are found in organisms that encode haem biosynthesis and lack haem uptake 283 
systems   284 
285 
IsdG-type haem degrading monooxygenases are a family of proteins that are characterized by the 286 
presence of an antibiotic biosynthesis monooxygenase (ABM) domain followed by a loop region 287 
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(Reniere et al., 2011). To further test our proposal that IsdG-like proteins play a role in haem 
biosynthesis, we analysed the distribution of these proteins in complete and annotated genomes and 
their co-occurrence with genes encoding haem biosynthesis and/or haem uptake systems. For this 
purpose, an organism was considered to have a de novo haem biosynthesis ability if at least 75% of the 
pathway was encoded in its genome. For the PPD pathway, besides the 75% rule either CgdC or CgdH 
had to be present in the organism’s genome. In addition, for organisms with the CPD pathway, ChdC 
had to be encoded in the genome. Also, an organism was considered to be able to perform haem 
uptake if its genome encoded a complete transport system with at least one haem binding protein 
(HmuT, IsdE or RV2003) (see Methods). 
Data showed that among the so far complete and annotated genomes (5060) more than 1/5 of the 
organisms contain genes encoding IsdG-like proteins (Supplementary Data 1). The IsdG-like proteins are 
more represented in Gram-positive organisms (79%) (Fig. 6A). The majority of IsdG-like containing 
organisms encode complete (or almost complete) haem biosynthesis and uptake systems (Fig. 6B). 
Interestingly, IsdG-like proteins were not found in organisms that synthesize haem through the 
alternative haem biosynthesis pathway.  
Within the 747 Gram-positive organisms that perform both haem biosynthesis and uptake, 422 (~56%) 
contained two or more genes coding for IsdG-like proteins. The remaining genomes contain only one 
IsdG-type protein but in ~50% of these organisms IsdG occurs together with genes coding for other 
haem monooxygenases belonging to the HemO, HmuO, ChuS/HmuS or HugZ families of haem 
monooxygenases (Fig. 6C). Within the 108 Gram-negative organisms, the majority (81%) encode two 
haem monooxygenases.  
Noteworthy, IsdG-like proteins are found in organisms that lack haem uptake systems but contain haem 
biosynthesis pathways. Moreover, over 90% of the organisms that apparently have incomplete haem 
biosynthesis or uptake systems encode IsdG homologues together with haem biosynthesis ChdC and/or 
CpfC associated enzymes. These organisms belong to Lactobacillus plantarum or Lactobacillus reitti 
species that are unable to perform haem biosynthesis, but when grown with haem (and menaquinone), 
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Altogether, the analysis showed that among the IsdG containing bacteria many of these organisms seem 
to rely only on haem biosynthesis pathways. Moreover, even the genomes that lack genes putatively 
involved in haem biosynthesis or uptake pathways still encode IsdG, ChdC and CpfC-like genes. Finally, 
the majority of the organisms with well-defined haem biosynthesis and uptake pathways contain two 
haem monooxygenases-like proteins, which supports the hypothesis that one haem monooxygenase 
could be used for haem degradation and the other could potentially interfere with haem biosynthesis, 
as shown in this work for S. aureus.  
Discussion 
We have investigated the way in which prokaryotes that obtain haem through haem biosynthesis and 
uptake pathways balance their high haem needs with the toxicity associated with free haem. We have 
shown that IsdG, one of the haem monooxygenases in the S. aureus haem uptake pathway, controls 
intracellular haem content through a protein-protein interaction with ferrochelatase that results in 
inhibition of iron-coproporphyrin chelatase activity. A comprehensive bioinformatics analysis showed 
that IsdG-like proteins are present in a significant number of prokaryotes that contain only the haem 
biosynthesis pathway. Altogether, the data allows us to propose that the IsdG protein family is not only 
the missing link between the two pathways, but also acts as the brake that avoids production of 
undesirably high intracellular haem levels.  
In several microorganisms, IsdG-type haem monooxygenases, including the S. aureus IsdG and IsdI, have 
been assigned a haem-degradation role in vitro (Skaar et al., 2004), and are required for growth when 
haemin is the only available iron source (Reniere and Skaar, 2008).  We observed that IsdI impairs 
growth when haem is formed through PPD or CPD pathways, which is consistent with the haem 
degrading activity of IsdI. In contrast, IsdG inhibited growth only when haem was generated by the CPD 
pathway, which suggests that IsdG interferes with the haem synthesis pathway.  
Experimentally, we have demonstrated that strains containing IsdG have lower amounts of intracellular 
haem formed via the haem biosynthesis route and IsdG has the ability to decrease the iron-
coproporphyrin chelatase activity of S. aureus CpfC. Furthermore, we showed by in vivo FLIM-FRET and 
fluorescence polarization binding assays that the two proteins interact and have generated a model for 
this interaction.  
Under our conditions, addition of haem did not repress expression of the S. aureus CPD pathway linked 
genes, as has been reported previously for several organisms. The only exception to this observation is 
with the Corynebacterium diphtheriae gtrR, which is repressed under haem replete conditions (Bibb et 
al., 2007). Thus, in general, haem does not serve as a feedback factor to repress its own synthesis at the 
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haem regulator transporter HrtAB (Torres et al., 2007). In agreement with this, when we treated 
cells with haemin, they exhibited induction of the first gene of the hrtBA operon. More 
significantly, we observed that expression of isdG was highly upregulated, indicating that IsdG may 
play a role in haem regulation. Furthermore, this upregulation translated into an increase of the IsdG 
protein abundance, as shown by FACS. Consistent with our results, IsdG, but not IsdI, has been reported 
to be regulated at the post-transcriptional level such that it is stabilized in the presence of haem and 
undergoes proteolytic degradation in the absence of haem (Reniere and Skaar, 2008; Reniere et al., 
2011). We observed a higher abundance of IsdG in S. aureus when it was grown in iron-replete 
medium, while other authors have reported that IsdG is more expressed upon addition of exogenous 
haemin to iron-starved cultures of S. aureus (Reniere and Skaar, 2008). These differences are most 
probably due to the experimental conditions used in the two assays 
The bioinformatics analysis reported in this work estimates that among bacteria that only synthesize 
haem endogenously approximately one third contain IsdG-like proteins. Even in organisms with a less 
well-defined haem biosynthesis pathway, IsdG-type enzymes coexist with ChdC and/or CpfC enzymes 
(Fig. S6B). This is in agreement with previous studies that have shown that the presence of IsdG is not 
restricted to organisms that have both the haem biosynthesis and acquisition machineries (Sousa et al., 
2013).  However, in many cases the genes encoding for IsdG-like enzymes are co-localised with genes for 
PPD and CPD pathways. Hence, IsdG may regulate both these routes for endogenous biosynthesis 
of haem. Our data support the proposal that in S. aureus this control occurs through the interaction of 
IsdG with CpfC, as the presence of IsdG strongly decreases ferrochelatase activity and the intracellular 
haem abundance. Although at this stage the interaction at the molecular level between IsdG and CpfC 
cannot be fully described due to the lack of detailed structural information, we hypothesize that this 
interaction may block the access of the substrate to the porphyrin binding cleft of CpfC.  
Until now there has been a great deal of focus on the mechanisms of haem uptake as a source of iron, 
whilst the question of how microbes prevent unwanted haem toxicity by fine tuning 
exogenously acquired haem with haem synthesized endogenously remains less understood.  
The scheme depicted in Fig. 7 summarises our current proposal for bacteria to maintain their 
intracellular free haem pool below hazardous levels. Organisms with both haem biosynthesis and uptake 
systems use external haem in two different ways. External haem is transported into the cytoplasm 
through dedicated systems, including those of the Isd-type, where it is either directly incorporated into 
apo-haemoproteins or degraded by IsdI, HemO, HmuO, ChuS/HmuS or HugZ- like proteins to release 
iron. On the other hand, haem also increases the abundance of IsdG to levels that are sufficient to 
interact with CpfC blocking its function, i.e, impairing the haem biosynthesis pathway. Hence, one of the 
haem monooxygenase enzymes would likely be dedicated to haem degradation to provide a source for 
12 
iron whilst the other would act to restrain internal haem biosynthesis. Moreover, in systems that only 402 
synthesize haem via an internal haem biosynthesis pathway and contain IsdG-like proteins, IsdG may 403 
play an important role in preventing excessive production of haem. 404 
405 
Collectively, our results show that the haem uptake and biosynthesis are not independent processes, 406 
and that IsdG-like proteins have a role in the crosstalk between these two systems which allow bacteria 407 
to adapt to a range of environments while avoiding haem toxicity. Therefore, we predict that the design 408 
of inhibitory drugs targeting the IsdG family of proteins will have a significant therapeutic benefit for the 409 
treatment of pathogenic infections.  410 
411 
412 
Experimental Procedures 413 
414 
Strains and growth conditions 415 
The strains used in this work are listed in Supplementary Table 3 and were grown under aerobic 416 
conditions, at 37 °C and 150 rpm. S. aureus was cultured in tryptic soy broth (TSB), with the exception of 417 
the cells that were used for RNA extraction that were cultured in Roswell Park Memorial Institute (RPMI) 418 
medium supplemented with 1% casamino acids. E. coli strains were grown in Luria-Bertani (LB), except 419 
E. coli expressing the pWhiteWalker plasmid that was grown in Brain Heart Infusion (BHI) medium.420 
Selection was achieved by addition of the indicated antibiotics, namely kanamycin (50 μg ml
−1
), 421 
erythromycin (20 μg ml
−1
 or 400 μg ml
−1




RNA isolation and quantitative real-time RT-PCR assays 424 
Overnight cultures of S. aureus were diluted to an optical density at 600 nm (OD600) of 0.1 on RPMI 425 
containing 1% casamino acids or RPMI containing 1% casamino acids supplemented with haemn (2 μM). 426 
Cells at an OD600 = 1 were treated with an ice-cold ethanol/phenol RNA protective solution (5%), 427 
centrifuged at 2000 x g for 5 min, and the pellets flash frozen in liquid nitrogen. For RNA isolation, 428 
pellets were thawed on ice, resuspended in 10 mM Tris pH 8 and lysed with 2 mg ml
-1
 lysozyme and 30429 
μg ml
-1
 lysostaphin at 37 °C, for 30 min. The lysates were transferred to Aurum RNA Binding Mini430 
Columns and total RNA was extracted using Aurum™ Total RNA Mini Kit (Bio-Rad), following the 431 
manufacturer´s instructions. Contaminating DNA was removed using Ambion® TURBO DNA-free™DNase 432 
kit (Life Technologies), and RNA concentration and purity were evaluated in a Nanodrop ND-1000 UV–433 
visible spectrophotometer (Thermo Fisher Scientific). 434 
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For the cDNA synthesis, 800 ng of RNA was reverse transcribed with the Transcriptor High Fidelity cDNA 
Synthesis Kit (Roche) using the Anchored-oligo (dT)18 and Random Hexamer primers. Quantitative real-
time RT-PCR assays were done in a LightCycler® 480 (Roche) using the oligonucleotides listed in 
Supplementary Table 4 and the LightCycler® 480 SYBR Green I Master kit (Roche). Relative quantification 
of each gene is shown in relation to the 16S rRNA reference gene, whose expression does not vary 
under the tested conditions, and using the comparative CT method. Assays were done for two 
independent biological samples analysed in triplicate. 
Gene cloning 
The genes encoding S. aureus Newman IsdG and IsdI were amplified, by standard PCR reactions, from 
genomic DNA using the Phusion High-Fidelity DNA Polymerase (Thermo Fischer) and the 
oligonucleotides described in Supplementary Table 4. DNA fragments were cloned into either pET-23b 
or pET-28a vectors (Novagen) to produce wild type proteins and N-terminal His-Tag fused proteins, 
respectively. All plasmids were confirmed for gene integrity by DNA sequencing.  
For the complementation experiments, plasmid pET-23b containing combinations of cpfC, chdC, cgoX, 
isdG, isdI of S. aureus (Sa), namely pET-23b-SacgoXcpfCchdCisdG, pET-23b-SacgoXcpfCchdCisdI, were 
generated by the link and lock methodology (McGoldrick et al., 2005). 
For the Förster Resonance Energy Transfer (FRET) studies, the isdG, isdI, cpfC and chdC genes amplified 
from S. aureus genomic DNA, as described above, were cloned into pBCB plasmids, which were kindly 
provided by Mariana Pinho (ITQB-NOVA, Portugal).  
CpfC and ChdC proteins fused at the N-terminal to GFP were generated by cloning the respective genes 
into SphI/SpeI-pBCB1-gfp vector whereas IsdG, IsdI, CpfC and ChdC were fused at the C-terminal to 
mCherry (mCh) by cloning into the KpnI/NheI-pBCB7-mCh vector. After confirmation of the correct 
sequence of the fusion genes, BL21(DE3)Gold cells were used as recipient for the generated plasmids 
and analysed by FRET.  
For the flow cytometry experiments, the S. aureus isdG gene was cloned into the EcoRI/KpnI restriction 
sites of pWhiteWalker3 (kind gift of Simon Foster, University of Sheffield, UK) to generate the in-frame 
fusion isdG-gfp (pWW-isdG-gfp). Plasmid pWhiteWalker3 that expresses only GFP (pWW-gfp) was also 
constructed to be used as control. For this purpose, a gBlock gene fragment of 244 bp that includes a 
ribosomal binding site and the N-terminal sequence of GFP (Integrated DNA Technologies) was cloned 
into EcoRI/NcoI-pWW-isdG-gfp. The correct sequence of the two recombinant plasmids was confirmed, 
and after electroporation into S. aureus the fluorescence level of GFP was analysed by flow cytometry. 
14 











Plasmid pET-23b harbouring combinations of genes of S. aureus cgoX, cpfC, chdC, isdG, isdI, and E. coli 
ppfC were transformed into competent cells of E. coli ferrochelatase mutant ΔppfC (formerly ΔvisA, kind 
gift from Mark O’Brian, State University of New York at Buffalo, New York, USA) (Frustaci and O’Brian, 
1993). Overnight cultures were grown in LB supplemented with ampicillin and 5 μM haemin and 1 ml 
aliquots of cells were centrifuged at 1700 x g for 5 min and washed three times with LB. These pellets 
were used to inoculate LB-ampicillin, and growth was monitored for 8 h by measuring the optical density 
at 600 nm (OD600) in a spectrophotometer (Multiskan™ GO, ThermoFisher Scientific). Assays were done 
for two independent biological samples. 
Infection assays 
Murine macrophages J774A.1 (5 x 10
5
 cells/ml) (LGC Promochem) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% of fetal bovine serum, 100 μM of non-essential amino 477 
acids (Gibco), 50 U ml
-1
 of penicillin (Gibco), and 50 μg ml
-1
 of streptomycin (Gibco) in 24-well plates, at 478 
37°C in a 5% CO2-air atmosphere. Prior to infection, macrophages were activated with 5 μg ml
-1
 LPS 479 
(Sigma) and 1 μg ml
-1
IFN-Υ (Sigma), for 5 h. S. aureus wild type and ΔcpfC mutant were inoculated, 480 
separately, in TSB medium and grown overnight. The cultures were re-inoculated in TSB, and 4 ml of 481 
cells grown to an OD600= 0.4 were centrifuged at 4300 x g for 5 min, and washed three times with PBS. 482 




) and used to infect the483 
murine macrophages. After 30 min of infection, at 37 °C, cells were washed twice with PBS and 484 
incubated with 50 μg ml
-1
 of gentamycin, at 37 °C, for 10 min, to prevent extracellular bacterial growth.485 
Immediately after the addition of DMEM (time zero) and 2 and 4 h later, macrophages were collected, 486 
lysed with 2% of saponin and the number of intracellular bacteria was determined by CFU counting on 487 
TSB agar plates, which also contained 4 μM haemin to allow for the growth of the ferrochelatase mutant 488 
strain. Experiments were done for three independent biological samples assayed in duplicate. 489 
Production of recombinant proteins 490 
For the purification of S. aureus ferrochelatase CpfC, pET-23b-SahemH was transformed into 491 
BL21STAR(DE3) pLysS (Novagen) competent cells that were grown in LB medium at 37 °C and 150 rpm. 492 
Cells at an OD600 of 0.6 were induced by addition of 400 µM of isopropyl β-D-1-thiogalactopyranoside 493 
(IPTG) in the presence of 8 mg ml
−1
 of FeSO4 and grown for an additional 16-20 h, at 20 °C. For the494 
production of S. aureus IsdG and IsdI, plasmids pET-28b-SaisdG and pET-28b-SaisdI were transformed, 495 
separately, in competent cells of E. coli BL21(DE3)Gold. Cells were grown in LB medium until reaching an 496 
OD600=0.7, and the protein expression was induced by addition of 1 mM of IPTG to the medium, and 497 
cells grown at 30°C for 3 h. Cells were harvested by centrifugation (10000 x g, 15 min, 4 °C), and the 498 
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pellets were resuspended in 50 mM Tris-HCl pH 7.5 (Buffer A). Cells were disrupted in a French press 
operating at 1000 Psi, and centrifuged at 27216 x g, at 4°C, for 15 min. The supernatant was applied 
onto a Ni-Sepharose chelating fast flow column (GE Healthcare), previously equilibrated with buffer A 
supplemented with 10 mM of imidazole, and the proteins were eluted at 400 mM of imidazole and 
dialysed against buffer A supplemented with NaCl (150-400 mM). Proteins with level of purity >95%, as 
judged by SDS-PAGE, were concentrated in an Amicon Stirred Ultrafiltration Cell using a 10 kDa 
membrane (Millipore) and frozen until use.  
Enzymatic activities 
Catalase activity 
Overnight cultures of S. aureus wild type, and ΔcpfC mutants were grown in TSB only or supplemented 
with 4 μM haemin to an OD600 of 1. Cells were pelleted by centrifugation (10000 x g, 10 min), 
resuspended in buffer A and incubated with 7 μg of lysostaphin for 45 min, at 37 °C. The protein 
concentration of the cell lysates was determined using the Pierce Bicinchoninic acid Protein Assay 
(Thermo Scientific) and Sigma protein standards. For the catalase activity assays, approximately 26 μg of 
cells lysate proteins were added to buffer A containing 10 mM H2O2. The catalase activity was measured 





a Shimadzu UV-1700 spectrophotometer. Assays were done in triplicate. 
Ferrochelatase activity 
The assays were performed under anaerobic conditions in a Coy model A-2463 and Belle Technology 
chamber equipped with a Shimadzu UV-1800 spectrophotometer. For the preparation of coproporphyrin 
III (copro III) solution, 1–2 drops of 25% NH4OH was added to 1-3 mg of copro III powder followed by 
addition of 1 ml of water. Copro III concentration was determined spectrophotometrically in 0.1 M HCl 




).  For the ferrochelatase assay, CpfC (0.3μM) was pre-incubated withIsdI or IsdG
(1:10 molar ratio) at room temperature, for 10 min. Next, these proteins were added to the reaction 
mixture that contained copro III (10 μM) and (NH4)2Fe(SO4)2 (10 μM) in buffer Tris-HCl pH 8.0. The IsdG 
titration experiments, were performed using IsdG concentrations of 0.3, 0.7, 1.7 and 3.4 μM, which 
correspond to 1:1, 1:2, 1:5 and 1:10 stoichiometry relative to the concentration of CpfC. The chelatase 





). Assays were done in triplicate.
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S. aureus wild type and ΔisdG mutant cells were grown for 8h and then diluted in TSB in the presence of
400 μM of aminolaevulinic acid. Cells were harvested by centrifugation (8000 x g, 5 min, 4 ᵒC), washed 
and resuspended in buffer A, and incubated with lysostaphin, at 37 ᵒC, for 45 min. The supernatant was 
collected by centrifugation and the intracellular haem was quantified essentially as previously described 
(Wolf et al., 1984; Levicán et al., 2007). Cell extracts (250 μL) were mixed with the same volume of a 
solution containing 0.5 M NaOH and 2.5 % Triton-X-100, and the haematin formation was determined 
measuring the absorbance at 575 nm in a spectrophotometer Shimadzu UV-1700. Haemin from Frontier 
Scientific was used as standard. 
Mass spectrometry of tetrapyrrole products 
The plasmids pET-23b containing combinations of cgoX, cpfC, chdC, isdG and isdI were inserted into E. 
coli ferrochelatase mutant ΔppfC. Cells were prepared as described above for the complementation 
experiments, and inoculated in LB medium to an OD600~0.05 and grown for 7 h. Cells were harvested by 
centrifugation at 10000 x g for 10 min, resuspended in buffer A, disrupted at 900 Psi in a French press, 
and centrifuged at 17000 x g for 30 min, at 4 °C. Protein content of the cell-free lysates was quantified 
using a Nanodrop ND-2000C (Thermo Scientific). Lysates with the equal protein concentration were 
treated for haem extraction. Briefly, proteins were precipitated by incubation of lysates with an 
acetone:HCl (19:1 vol/vol) mixture for 20 min, at room temperature, and removed by centrifugation at 
14000 x g for 2 min. Following addition to supernatants of 1 ml of cold water, few milligrams of (NH4)2SO4 
(Panreac) and 300 µl of pure ethyl acetate (Sigma), haem was extracted from the organic phase after 
centrifugation at 14000 x g for 2 min. Samples were resolved by HPLC-MS on an Ace 5 AQ column 
attached to an Agilent 1100 series HPLC, equipped with a diode array detector and coupled to a 
micrOTOF-Q II (Bruker) mass spectrometer. Separation of the products was achieved by applying a 
gradient composed by 0.1% TFA and acetonitrile, at a flow rate of 0.2 ml min
−1
. The column was first
equilibrated with 20% solvent B, and after sample injection the concentration of solvent B was increased 
up to 100% during 50 min. Haem quantification was done by measuring the area of absorbance peak at 
400 nm for m/z 616 (haem).  
Flow cytometry 
Overnight cultures of S. aureus RN4220 transformed with pWW-isdG-gfp, pWW-isdI-gfp or pWW-gfp 
were grown in TSB to an OD600~1.5, diluted to an OD600 of 0.1 in TSB supplemented with 10 μM of IPTG, 
and grown for one extra hour. At this stage, cells were divided in 10 ml aliquots and grown for 4 h in the 
absence and in the presence of 5 μM haemin or 400 μM of aminolaevulinic acid. Cells (1 ml) were 562 
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collected by centrifugation at 11400 x g for 1 min, and the pellets were washed 3 times with PBS, diluted 
in PBS to an OD600 of 0.1 and analysed in a Cell Sorter S3e™ (Biorad). For each sample, at least, 300,000 
cells were collected and analysed with the FlowJo programme (Tree Star), and three biological samples 
were measured for each condition. 
Fluorescent labelling of CpfC 
S. aureus CpfC was covalently labelled with 5-dimethylaminonaphthalene-1-sulfonyl chloride (dansyl
chloride) according to the manufacturer´s instructions (Invitrogen). Briefly, recombinantly produced and 
purified S. aureus CpfC (7.5 mg ml
-1
), solubilized in 0.1 M sodium bicarbonate pH 8.6, was incubated in a




dimethylformamide) for 1 h at 4°C, in the dark and under
continuous stirring. The reaction was quenched by the addition of hydroxylamine (1.5 M, pH 8.5), and the 
mixture was then loaded onto a PD-10 column (GE Healthcare) equilibrated with buffer A in order to 
remove the excess of free dye by gel filtration. The CpfC:dansyl labelling ratio was determined by 




) (Gustiananda et al., 2004)  and of




) (Gasteiger et al., 2005), and estimated to be 0.97.
Pull down assays 
Interaction of CpFc and Isds proteins was investigated by pull-down assays. For this purpose, 
recombinant N-terminal polyhistidine tagged-CpfC was expressed from pET-23b plasmid and purified as 
described in the previous section. In order to immobilize the overproduced His-tagged-CpfC, 14 mg of 
protein was loaded onto a Ni-Sepharose fast flow column (GE Heathcare). The column was next washed 
with 10 mM Tris–HCl, pH 8.0 containing several concentrations of imidazole, and the His-tagged CpfC 
was eluted at 60 mM imidazole.  
In parallel, E. coli BL21(DE3)Gold supernatants expressing non-His tagged versions of S. aureus IsdG and 
IsdI (pET-23b) were prepared, separately, as described above. The supernatants were loaded into the 
CpfC-bound Ni-Sepharose chelating column and washed with buffer 10 mM Tris–HCl, pH 8.0, and 
proteins that were subsequently eluted with 60 mM imidazole were analysed by SDS-PAGE. To discard 
non-specific interactions, control experiments were done similarly using the same supernatants loaded 
into columns with no bounded CpfC-His protein.  
Steady-state fluorescence anisotropy measurements 
18 
Dansyl-labeled CpfC (0.67 µM) was incubated with variable concentrations of IsdG or IsdI in buffer A. 594 







where IVV and IVH are the fluorescence intensities (blank subtracted) of the vertically and horizontally 596 
polarized emission, when the sample is excited with vertically polarized light, respectively. The G factor 597 
(G= IHV/IHH) is an instrument correction factor which takes into account the transmission efficiency of the 598 
monochromator to the polarization of the light. Measurements were performed at 25 
o
C on a Fluorolog-599 
3-21 spectrofluorometer (Horiba Jobin Yvon) with automated dual polarizers using 5-mm path length 600 
quartz cuvettes. The excitation wavelength was 340 nm with a bandwidth of 6 nm, and the fluorescence 601 
emission was recorded at 530 nm with 5 nm bandwidth. Kd and <r>B parameters were obtained by 602 
fitting the experimental data (steady-state fluorescence anisotropy, <r> versus P2 , the total603 
concentration of the binding partner 2 (dimeric IsdG or IsdI)) using the equation: 604 




where [P1]t represents the total concentration of the binding partner 1. The concentration of CpfC was 606 
fixed to 0.67 µM during the non-linear regression and assumed that the fluorescently-labelled protein is 607 
monomeric in solution; [P2]t is the total concentration of the binding partner 2. Binding stoichiometry 608 
was considered 1:1; <  >  represents the steady-state fluorescence anisotropy of the free protein.609 
<r>F= 0.165 (fixed during the analysis); and <  >$  the steady-state fluorescence anisotropy of the610 
bound protein. 611 
Förster Resonance Energy Transfer (FRET) and Fluorescence Lifetime Imaging Microscopy (FLIM) 612 
E. coli BL21(DE3)Gold were co-transformed with plasmids that express combinations of CpfC, ChdC, IsdI613 
and IsdG fused to GFP and mCherry (mCh) fluorophore proteins, namely pBCB-cpfC-gfp and pBCB-isdG-614 
mCh; pBCB-cpfC-gfp and pBCB-isdI-mCh; pBCB-chdC-gfp and pBCB-isdG-mCh; and pBCB-chdC-gfp and 615 
pBCB-isdI-mCh (Supplementary Table 1). Cells grown overnight in LB were sub-cultured into LB medium 616 
to an OD600 of 0.15, supplemented with 1 mM IPTG and grown for 4 h. Cells (2 ml) were centrifuged at 617 
4300 x g for 3 min, and fixed by incubation with 4% formaldehyde (vol/vol) in PBS, at room temperature, 618 
for 30 min and 90 rpm, washed with PBS and immobilized on 8 well μ-slides (Ibidi, slides, Germany) for 619 
FRET-FLIM experiments.  620 
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All measurements were acquired in a Leica TCS SP5 (Leica Microsystems CMS GmbH, Mannheim, 621 
Germany) inverted confocal microscope (DMI6000). A 63x apochromatic water immersion objective 622 
with a NA of 1.2 (Zeiss, Jena Germany) was used for all experiments. GFP and mCherry were excited 623 
respectively with the 476 nm and 514 nm lines from an Argon laser, and fluorescence emission was 624 
collected in the 485-540 nm range for GFP, and 580-700 nm for mCherry. In these conditions, spectral 625 
bleed-through was negligible. 626 
Fluorescence lifetime imaging microscopy (FLIM) measurements were performed by time correlated 627 
single photon counting (TCSPC) using the confocal microscope coupled to a multiphoton Titanium: 628 
Sapphire laser (Spectra-Physics Mai Tai BB, Darmstadt, Germany) as the excitation source. FLIM data 629 
was acquired during 90-180 seconds to achieve reasonable photon statistics. The excitation wavelength 630 
was set to 840 nm and emission light was selected with a dichroic beam splitter with an excitation SP700 631 
short-pass filter and an emission 525±25 nm band-pass filter inserted in front of the photomultiplier. 632 
Images were acquired using a Becker and Hickl SPC 830 module. Fluorescence decays for each cell were 633 
calculated by integrating the FLIM data for all pixels of each individual cell. Fluorescence lifetimes were 634 
obtained by analysing the fluorescence decays through a least square iterative re-convolution of decay 635 
functions with the instrument respons  function (IRF) using the software SPCImage (Becker and Hickl, 636 
Berlin, Germany). Intensity-weighted mean fluorescence lifetime (〈&〉) of multiexponential decays were637 
calculated as 〈&〉 = ∑ )** &* , were )* are the pre-exponential factors and &* are the individual lifetime638 
values. Average FRET efficiencies in each cell can be determined from <E> = 1-  〈&〉DA/〈&〉D, where 〈&〉DA 639 
and <τ>D are the donor intensity-weighted mean fluorescence lifetime in the presence or absence of 640 
acceptor, respectively. Assays were done for two independent biological samples and FRET efficiencies 641 
were determined for several cells. 642 
643 
Genomic analysis 644 
A dataset composed of 5060 complete prokaryotic genomes was downloaded from RefSeq (June 2016) 645 
(Pruitt et al., 2004). These correspond to all complete genomes available at the time in RefSeq. 646 
Taxonomic information was retrieved from NCBI and genomes were grouped by phylum or class. 647 
Homologous proteins involved in the several steps of haem biosynthesis and uptake (Urogen III 648 
synthesis: GtrR, GsaM, PbgS, HmbS and UroS; PPD haem biosynthesis UroD-(CgdC/CgdH)-649 
(PgoX/PgdH1/PgdH2)-PpfC; alternative haem biosynthesis: AhbABCD; S. aureus haem biosynthesis 650 
variant: UroD-CgoX-CpfC-ChdC; Staphylococcus haem uptake and degradation: HstABC, IsdABCDEFGHI-651 
SrtB, B. subtilis haem uptake: IsdCEDFGX1X2-Hal; haem monooxygenases IsdG-type: MhuD, HmuQ/D; 652 
other haem monooxygenases: HemO, HmuO, HmuS, HugZ, ChuS; haem transporters: HmuTUV, IsdEFD, 653 
HtsABC, Rv2002c-Rv2003-Rv2006c) were identified by BLAST (Altschul et al., 1997) (E-value smaller than 654 
10
-10
 and local amino acid identity of at least 25%). To distinguish between haem transporters systems 655 
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from siderophores and/or cobalamin importers, sequences from biochemically-characterized 
transporters were used as queries as well. All query proteins are listed in Supplementary Data 1. When 
relevant, PFAM-A domain annotations were obtained by using the HMM approach as available at PFAM 
(Finn et al., 2016). Query coverage, gene fusions and genomic organization were also used for the 
identification of true positive hits. Due to their small length, to distinguish between the different IsdG 
homologous, an all versus all blast of putative IsdGs and query sequences and an alignment were 
performed. Hits were classified according to their best hit based on sequence identity, conservation of 
the catalytic triad (for HmoA) and sequence length. Selected IsdG-type homologous identified by Blast 
were aligned with ClustalO (Sievers et al., 2011) and a maximum likelihood tree reconstructed with 
IQTree (Best-model selection WAG+G4)(Nguyen et al., 2015).  
To distinguish between “bona fide” CgdH from highly similar non-functional CgdHs, all genomes were 
also queried for the presence of non-functional CgdH in a similar way as in Dailey et al 2015 (Dailey et 
al., 2015).  To distinguish between ChdC and chlorite dismutases, sequences were aligned with ClustalO 
and a phylogenetic tree performed.  Sequences corresponding to chlorite dismutases were discarded 
based on the conservation of the catalytic residues and position within a phylogenetic tree.  A haem 
biosynthesis pathway was only considered to be present in a genome if: 1) 80% of its genes were 
identified and 2) if the characteristic proteins were present, CgdH and/or CgdC for classical haem 
pathway and ChdC for S. aureus variant. Cases in which a variant of the canonical pathways above 
described were present and/or missing one gene were assigned as hybrid or incomplete. Due to the high 
sequence similarity between genes involved in haem d1 biosynthesis with genes from the haem 
alternative pathway (Bali et al., 2011), in organisms containing cd1 nitrite reductase, the haem 
alternative pathway identified genes were considered to be involved in haem d1 synthesis instead.  
Statistical analysis 
In all figures, error bars represent the standard deviation of at least two biological samples. Statistical 
differences were calculated by the two-tailed Student's t-test using GraphPad Prism (GraphPad 
Software). 
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Figure 1. Three different haem biosynthesis pathways that diverge from uroporphyrin III. The enzymes in 
the three pathways are conserved between aminolaevulinic acid (δAla) and uroporphyrinogen III. The 
protoporphyrin dependent (or classical) pathway is boxed in grey and converts uroporphyrinogen III into 
haem using protoporphyrin as an intermediate. The CPD pathway is represented in red and the sirohaem 
dependent pathway (alternative haem biosynthesis pathway) highlighted in blue.  
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Figure 2. S. aureus IsdG and IsdI impair haem formation. (A) Growth of E. coli ∆ppfC cells complemented 
with S. aureus CgoX!CpfC!ChdC alone, in the presence of S. aureus IsdG (CgoX!CpfC!ChdC!IsdG) or S. 
aureus IsdI (CgoX!CpfC!ChdC!IsdI). (B) HPLC!MS profile of cells depicted in (A), with peaks corresponding 
to haem (m/z = 616; peak 1), iron!coproporphyrin III (m/z = 708; peak 2), and protoporphyrin IX (m/z = 
553; peak 3). (C) Growth of E. coli ∆ppfC cells complemented with E. coli PpfC alone and together with S. 
aureus IsdG (PpfC!IsdG) or S. aureus IsdI (PpfC!IsdI). Experiments were performed for two independent 
biological samples.  
86x74mm (300 x 300 DPI) 
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Figure 3. Influence of S. aureus IsdG on the CPD pathway. (A)  IsdG decreases the ferrochelatase activity of 
S. aureus CpfC while IsdI does not impair the activity. (B) Inhibition of S. aureus CpfC ferrochelatase
activity increases with IsdG concentration. (C) Intracellular haem quantification of S. aureus wild type and 
∆isdG mutant for cells grown in the presence of 400 (M of aminolaevulinic acid (Ala).  
In (A) and (B), activities were measured in reaction mixtures containing CpfC alone, or with the addition of 
IsdG or IsdI, using coproporphyrin III (10 (M) and (NH4)2Fe(SO4)2 (10 (M) as substrates. In (B), IsdG was 
used in the following concentrations: 0.3, 0.7, 1.7 and 3.4 (M. Data depict the mean and standard deviation 
of three samples using a two3tailed unpaired Student’s t3test (** p < 0.01).  
123x45mm (300 x 300 DPI) 
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